Archives

  • Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of CAR-T Associated Neurotoxicity

    Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in an exploratory Phase 2 clinical

    Read More
  • Kodiak Sciences Treats First Patients in DAZZLE Pivotal Study of KSI-301 in Wet Age-Related Macular Degeneration

    Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases,

    Read More
  • NIH strategic research plan addresses growing tickborne diseases threat

    The incidence of reported cases of tickborne diseases in the United States has significantly increased in recent years. It is

    Read More
  • Transplant Genomics, Inc. Confirms TruGraf® Will Receive Medicare Coverage Effective November 25, 2019

    Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive serial monitoring guided by

    Read More
  • Working as Pharmacist at Steel Authority of India Limited (SAIL), Bhilai

    Pharmacist Total No of Vacancies: 07 Educational Qualification: Degree in Pharmacy Or 10+2/Intermediate in science with Diploma in Pharmacy of minimum

    Read More

Archive

Offers